Advanced Cancer Therapeutics LLC - Company Review
Advanced Cancer Therapeutics LLC - Company ReviewSummary
Advanced Cancer Therapeutics LLC (ACT) is a biotechnology company that discovers and develops novel cancer therapeutics. The company’s products include ACT-GRO-777, PU27, PFKFB3, choline kinase and human papillomavirus vaccine. Its ACT-GRO-777 is an aptamer that binds to a protein called nucleolin on the surface of many cancer cells, which cause the death of cancer cells. ACT offers products for the treatment of leukemia, prostate cancer, renal cancer and breast cancer. The company also conducts open label, dose escalation, multicenter clinical trial for patients with advanced solid tumors. It has partnership with cancer centers located in Houston, San Antonio, Georgetown and Louisville, the US. ACT is headquartered in Louisville, Kentucky, the US.
This comprehensive company report of Advanced Cancer Therapeutics LLC provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.